Last updated: February 25, 2026
Sponsor: Wake Forest University Health Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Constipation
Treatment
Senna Tab
Dulcolax Suppositories
Clinical Study ID
NCT06335797
IRB00110733
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women ages 18 and older scheduled to undergo vaginal pelvic organ prolapse repair
Exclusion
Exclusion Criteria:
Women younger than 18 years old
Those unable to provide consent
Preexisting chronic laxative use
Conditions that could affect bowel function including, inflammatory bowel disease,irritable bowel syndrome, colorectal cancer, rectovaginal fistula; concurrent bowelsurgery; intraoperative bowel injury
Study Design
Total Participants: 88
Treatment Group(s): 2
Primary Treatment: Senna Tab
Phase:
Study Start date:
October 16, 2024
Estimated Completion Date:
May 31, 2027
Study Description
Connect with a study center
Wake Forest University Health Sciences
Winston-Salem, North Carolina 27157
United StatesSite Not Available
Wake Forest University Health Sciences
Winston-Salem 4499612, North Carolina 4482348 27157
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.